APO Research
Talk to an analyst

APO RESEARCH · REPORT

Memantine

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Memantine Market Analysis and Forecast 2026-2032

26 December 2025191 pages

Choose your research edition.

Industry ResearchMemantine Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Memantine Industry Growth and Trends Forecast to 203288 pages · $3,450 USDMarket StructureGlobal Memantine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Memantine Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Memantine Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Memantine market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Memantine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Memantine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Memantine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Memantine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Memantine include Eisai Co, Johnson & Johnson, Novartis AG, Ono Pharmaceutical Co Ltd, H Lundbeck A/S, Daiichi Sankyo Company Limited and Allergan, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Memantine, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Memantine, also provides the revenue of main regions and countries. Of the upcoming market potential for Memantine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Memantine revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Memantine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Memantine revenue, projected growth trends, production technology, application and end-user industry.

Memantine Segment by Company

Eisai Co

Johnson & Johnson

Novartis AG

Ono Pharmaceutical Co Ltd

H Lundbeck A/S

Daiichi Sankyo Company Limited

Allergan

Memantine Segment by Type

Memantine Powder

Memantine Capsule

Memantine Tablet

Memantine Segment by Application

Hospital Pharmacy

Retail Pharmacy

Memantine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Memantine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Memantine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Memantine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Memantine in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Memantine company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Memantine revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Memantine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Memantine Powder Major Player Table 3. Memantine Capsule Major Player Table 4. Memantine Tablet Major Player Table 5. Global Memantine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Hospital Pharmacy Major Player Table 7. Retail Pharmacy Major Player Table 8. Memantine Industry Trends Table 9. Memantine Industry Drivers Table 10. Memantine Industry Opportunities and Challenges Table 11. Memantine Industry Restraints Table 12. Global Memantine Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Memantine Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Memantine Market Share by Region (2021-2026) Table 15. Global Memantine Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Memantine Market Share by Region (2027-2032) Table 17. Global Memantine Revenue by Players (US$ Million) & (2021-2026) Table 18. Global Memantine Revenue Market Share by Players (2021-2026) Table 19. Global Memantine Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global Memantine Key Players Headquarters & Area Served Table 21. Global Memantine Players, Product Type & Application Table 22. Global Memantine Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global Memantine by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global Memantine Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Memantine Revenue by Type (2021-2026) & (US$ Million) Table 27. Global Memantine Revenue by Type (2027-2032) & (US$ Million) Table 28. Global Memantine Revenue Market Share by Type (2021-2026) Table 29. Global Memantine Revenue Market Share by Type (2027-2032) Table 30. Global Memantine Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Memantine Revenue by Application (2021-2026) & (US$ Million) Table 32. Global Memantine Revenue by Application (2027-2032) & (US$ Million) Table 33. Global Memantine Revenue Market Share by Application (2021-2026) Table 34. Global Memantine Revenue Market Share by Application (2027-2032) Table 35. Eisai Co Company Information Table 36. Eisai Co Business Overview Table 37. Eisai Co Memantine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Eisai Co Memantine Product Portfolio Table 39. Eisai Co Recent Development Table 40. Johnson & Johnson Company Information Table 41. Johnson & Johnson Business Overview Table 42. Johnson & Johnson Memantine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Johnson & Johnson Memantine Product Portfolio Table 44. Johnson & Johnson Recent Development Table 45. Novartis AG Company Information Table 46. Novartis AG Business Overview Table 47. Novartis AG Memantine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Novartis AG Memantine Product Portfolio Table 49. Novartis AG Recent Development Table 50. Ono Pharmaceutical Co Ltd Company Information Table 51. Ono Pharmaceutical Co Ltd Business Overview Table 52. Ono Pharmaceutical Co Ltd Memantine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Ono Pharmaceutical Co Ltd Memantine Product Portfolio Table 54. Ono Pharmaceutical Co Ltd Recent Development Table 55. H Lundbeck A/S Company Information Table 56. H Lundbeck A/S Business Overview Table 57. H Lundbeck A/S Memantine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. H Lundbeck A/S Memantine Product Portfolio Table 59. H Lundbeck A/S Recent Development Table 60. Daiichi Sankyo Company Limited Company Information Table 61. Daiichi Sankyo Company Limited Business Overview Table 62. Daiichi Sankyo Company Limited Memantine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Daiichi Sankyo Company Limited Memantine Product Portfolio Table 64. Daiichi Sankyo Company Limited Recent Development Table 65. Allergan Company Information Table 66. Allergan Business Overview Table 67. Allergan Memantine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Allergan Memantine Product Portfolio Table 69. Allergan Recent Development Table 70. North America Memantine Revenue by Type (2021-2026) & (US$ Million) Table 71. North America Memantine Revenue by Type (2027-2032) & (US$ Million) Table 72. North America Memantine Revenue by Application (2021-2026) & (US$ Million) Table 73. North America Memantine Revenue by Application (2027-2032) & (US$ Million) Table 74. North America Memantine Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 75. North America Memantine Revenue by Country (2021-2026) & (US$ Million) Table 76. North America Memantine Revenue by Country (US$ Million) & (2027-2032) Table 77. Europe Memantine Revenue by Type (2021-2026) & (US$ Million) Table 78. Europe Memantine Revenue by Type (2027-2032) & (US$ Million) Table 79. Europe Memantine Revenue by Application (2021-2026) & (US$ Million) Table 80. Europe Memantine Revenue by Application (2027-2032) & (US$ Million) Table 81. Europe Memantine Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 82. Europe Memantine Revenue by Country (2021-2026) & (US$ Million) Table 83. Europe Memantine Revenue by Country (US$ Million) & (2027-2032) Table 84. China Memantine Revenue by Type (2021-2026) & (US$ Million) Table 85. China Memantine Revenue by Type (2027-2032) & (US$ Million) Table 86. China Memantine Revenue by Application (2021-2026) & (US$ Million) Table 87. China Memantine Revenue by Application (2027-2032) & (US$ Million) Table 88. Asia Memantine Revenue by Type (2021-2026) & (US$ Million) Table 89. Asia Memantine Revenue by Type (2027-2032) & (US$ Million) Table 90. Asia Memantine Revenue by Application (2021-2026) & (US$ Million) Table 91. Asia Memantine Revenue by Application (2027-2032) & (US$ Million) Table 92. Asia Memantine Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 93. Asia Memantine Revenue by Region (US$ Million) & (2021-2026) Table 94. Asia Memantine Revenue by Region (US$ Million) & (2027-2032) Table 95. SAMEA Memantine Revenue by Type (2021-2026) & (US$ Million) Table 96. SAMEA Memantine Revenue by Type (2027-2032) & (US$ Million) Table 97. SAMEA Memantine Revenue by Application (2021-2026) & (US$ Million) Table 98. SAMEA Memantine Revenue by Application (2027-2032) & (US$ Million) Table 99. SAMEA Memantine Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 100. SAMEA Memantine Revenue by Country (2021-2026) & (US$ Million) Table 101. SAMEA Memantine Revenue by Country (US$ Million) & (2027-2032) Table 102. Research Programs/Design for This Report Table 103. Authors List of This Report Table 104. Secondary Sources Table 105. Primary Sources List of Figures Figure 1. Memantine Image Figure 2. Global Memantine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Memantine Market Size Share 2021 VS 2025 VS 2032 Figure 4. Memantine Powder Image Figure 5. Memantine Capsule Image Figure 6. Memantine Tablet Image Figure 7. Global Memantine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Memantine Market Size Share 2021 VS 2025 VS 2032 Figure 9. Hospital Pharmacy Image Figure 10. Retail Pharmacy Image Figure 11. Global Memantine Market Size (US$ Million) & (2021-2032) Figure 12. Global Memantine Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Memantine Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global Memantine Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global Memantine Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Memantine Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Memantine Revenue Market Share by Type (2021-2032) Figure 19. Global Memantine Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Memantine Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global Memantine Revenue Market Share by Application (2021-2032) Figure 22. North America Memantine Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Memantine Revenue Share by Type (2021-2032) Figure 24. North America Memantine Revenue Share by Application (2021-2032) Figure 25. North America Memantine Revenue Share by Country (2021-2032) Figure 26. United States Memantine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada Memantine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico Memantine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe Memantine Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Memantine Revenue Share by Type (2021-2032) Figure 31. Europe Memantine Revenue Share by Application (2021-2032) Figure 32. Europe Memantine Revenue Share by Country (2021-2032) Figure 33. Germany Memantine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France Memantine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. Memantine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy Memantine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain Memantine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia Memantine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands Memantine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries Memantine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China Memantine Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China Memantine Revenue Share by Type (2021-2032) Figure 43. China Memantine Revenue Share by Application (2021-2032) Figure 44. Asia Memantine Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia Memantine Revenue Share by Type (2021-2032) Figure 46. Asia Memantine Revenue Share by Application (2021-2032) Figure 47. Asia Memantine Revenue Share by Region (2021-2032) Figure 48. Japan Memantine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea Memantine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India Memantine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia Memantine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan Memantine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia Memantine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA Memantine Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA Memantine Revenue Share by Type (2021-2032) Figure 56. SAMEA Memantine Revenue Share by Application (2021-2032) Figure 57. SAMEA Memantine Revenue Share by Country (2021-2032) Figure 58. Brazil Memantine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina Memantine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile Memantine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia Memantine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru Memantine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia Memantine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel Memantine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE Memantine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey Memantine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran Memantine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt Memantine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Memantine Powder
  • Memantine Capsule
  • Memantine Tablet
Applications
  • Hospital Pharmacy
  • Retail Pharmacy
Companies covered
  • Eisai Co
  • Johnson & Johnson
  • Novartis AG
  • Ono Pharmaceutical Co Ltd
  • H Lundbeck A/S
  • Daiichi Sankyo Company Limited
  • Allergan

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Memantine Market by Type
  3. 1.2.1 Global Memantine Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Memantine Powder
  5. 1.2.3 Memantine Capsule
  6. 1.2.4 Memantine Tablet
  7. 1.3 Memantine Market by Application
  8. 1.3.1 Global Memantine Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Hospital Pharmacy
  10. 1.3.3 Retail Pharmacy
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Memantine Market Dynamics
  1. 2.1 Memantine Industry Trends
  2. 2.2 Memantine Industry Drivers
  3. 2.3 Memantine Industry Opportunities and Challenges
  4. 2.4 Memantine Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Memantine Market Perspective (2021-2032)
  2. 3.2 Global Memantine Growth Trends by Region
  3. 3.2.1 Global Memantine Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Memantine Market Size by Region (2021-2026)
  5. 3.2.3 Global Memantine Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Memantine Revenue by Players
  2. 4.1.1 Global Memantine Revenue by Players (2021-2026)
  3. 4.1.2 Global Memantine Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Memantine Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Memantine Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Memantine Key Players Headquarters & Area Served
  7. 4.4 Global Memantine Players, Product Type & Application
  8. 4.5 Global Memantine Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Memantine Market CR5 and HHI
  11. 4.6.3 2025 Memantine Tier 1, Tier 2, and Tier 3
5 Memantine Market Size by Type
  1. 5.1 Global Memantine Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Memantine Revenue by Type (2021-2032)
  3. 5.3 Global Memantine Revenue Market Share by Type (2021-2032)
6 Memantine Market Size by Application
  1. 6.1 Global Memantine Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Memantine Revenue by Application (2021-2032)
  3. 6.3 Global Memantine Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Eisai Co
  2. 7.1.1 Eisai Co Company Information
  3. 7.1.2 Eisai Co Business Overview
  4. 7.1.3 Eisai Co Memantine Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Eisai Co Memantine Product Portfolio
  6. 7.1.5 Eisai Co Recent Developments
  7. 7.2 Johnson & Johnson
  8. 7.2.1 Johnson & Johnson Company Information
  9. 7.2.2 Johnson & Johnson Business Overview
  10. 7.2.3 Johnson & Johnson Memantine Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Johnson & Johnson Memantine Product Portfolio
  12. 7.2.5 Johnson & Johnson Recent Developments
  13. 7.3 Novartis AG
  14. 7.3.1 Novartis AG Company Information
  15. 7.3.2 Novartis AG Business Overview
  16. 7.3.3 Novartis AG Memantine Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Novartis AG Memantine Product Portfolio
  18. 7.3.5 Novartis AG Recent Developments
  19. 7.4 Ono Pharmaceutical Co Ltd
  20. 7.4.1 Ono Pharmaceutical Co Ltd Company Information
  21. 7.4.2 Ono Pharmaceutical Co Ltd Business Overview
  22. 7.4.3 Ono Pharmaceutical Co Ltd Memantine Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Ono Pharmaceutical Co Ltd Memantine Product Portfolio
  24. 7.4.5 Ono Pharmaceutical Co Ltd Recent Developments
  25. 7.5 H Lundbeck A/S
  26. 7.5.1 H Lundbeck A/S Company Information
  27. 7.5.2 H Lundbeck A/S Business Overview
  28. 7.5.3 H Lundbeck A/S Memantine Revenue and Gross Margin (2021-2026)
  29. 7.5.4 H Lundbeck A/S Memantine Product Portfolio
  30. 7.5.5 H Lundbeck A/S Recent Developments
  31. 7.6 Daiichi Sankyo Company Limited
  32. 7.6.1 Daiichi Sankyo Company Limited Company Information
  33. 7.6.2 Daiichi Sankyo Company Limited Business Overview
  34. 7.6.3 Daiichi Sankyo Company Limited Memantine Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Daiichi Sankyo Company Limited Memantine Product Portfolio
  36. 7.6.5 Daiichi Sankyo Company Limited Recent Developments
  37. 7.7 Allergan
  38. 7.7.1 Allergan Company Information
  39. 7.7.2 Allergan Business Overview
  40. 7.7.3 Allergan Memantine Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Allergan Memantine Product Portfolio
  42. 7.7.5 Allergan Recent Developments
8 North America
  1. 8.1 North America Memantine Revenue (2021-2032)
  2. 8.2 North America Memantine Revenue by Type (2021-2032)
  3. 8.2.1 North America Memantine Revenue by Type (2021-2026)
  4. 8.2.2 North America Memantine Revenue by Type (2027-2032)
  5. 8.3 North America Memantine Revenue Share by Type (2021-2032)
  6. 8.4 North America Memantine Revenue by Application (2021-2032)
  7. 8.4.1 North America Memantine Revenue by Application (2021-2026)
  8. 8.4.2 North America Memantine Revenue by Application (2027-2032)
  9. 8.5 North America Memantine Revenue Share by Application (2021-2032)
  10. 8.6 North America Memantine Revenue by Country
  11. 8.6.1 North America Memantine Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Memantine Revenue by Country (2021-2026)
  13. 8.6.3 North America Memantine Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Memantine Revenue (2021-2032)
  2. 9.2 Europe Memantine Revenue by Type (2021-2032)
  3. 9.2.1 Europe Memantine Revenue by Type (2021-2026)
  4. 9.2.2 Europe Memantine Revenue by Type (2027-2032)
  5. 9.3 Europe Memantine Revenue Share by Type (2021-2032)
  6. 9.4 Europe Memantine Revenue by Application (2021-2032)
  7. 9.4.1 Europe Memantine Revenue by Application (2021-2026)
  8. 9.4.2 Europe Memantine Revenue by Application (2027-2032)
  9. 9.5 Europe Memantine Revenue Share by Application (2021-2032)
  10. 9.6 Europe Memantine Revenue by Country
  11. 9.6.1 Europe Memantine Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Memantine Revenue by Country (2021-2026)
  13. 9.6.3 Europe Memantine Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Memantine Revenue (2021-2032)
  2. 10.2 China Memantine Revenue by Type (2021-2032)
  3. 10.2.1 China Memantine Revenue by Type (2021-2026)
  4. 10.2.2 China Memantine Revenue by Type (2027-2032)
  5. 10.3 China Memantine Revenue Share by Type (2021-2032)
  6. 10.4 China Memantine Revenue by Application (2021-2032)
  7. 10.4.1 China Memantine Revenue by Application (2021-2026)
  8. 10.4.2 China Memantine Revenue by Application (2027-2032)
  9. 10.5 China Memantine Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Memantine Revenue (2021-2032)
  2. 11.2 Asia Memantine Revenue by Type (2021-2032)
  3. 11.2.1 Asia Memantine Revenue by Type (2021-2026)
  4. 11.2.2 Asia Memantine Revenue by Type (2027-2032)
  5. 11.3 Asia Memantine Revenue Share by Type (2021-2032)
  6. 11.4 Asia Memantine Revenue by Application (2021-2032)
  7. 11.4.1 Asia Memantine Revenue by Application (2021-2026)
  8. 11.4.2 Asia Memantine Revenue by Application (2027-2032)
  9. 11.5 Asia Memantine Revenue Share by Application (2021-2032)
  10. 11.6 Asia Memantine Revenue by Country
  11. 11.6.1 Asia Memantine Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Memantine Revenue by Country (2021-2026)
  13. 11.6.3 Asia Memantine Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Memantine Revenue (2021-2032)
  2. 12.2 SAMEA Memantine Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Memantine Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Memantine Revenue by Type (2027-2032)
  5. 12.3 SAMEA Memantine Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Memantine Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Memantine Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Memantine Revenue by Application (2027-2032)
  9. 12.5 SAMEA Memantine Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Memantine Revenue by Country
  11. 12.6.1 SAMEA Memantine Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Memantine Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Memantine Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst